Transcatheter aortic valve implantation (TAVI) has expanded beyond clinical evidence, with many of the 40,000 procedures performed lacking medical or cost-effectiveness justification.
This editorial highlights concerns that the clinical application of TAVI has expanded beyond the available evidence base, raising issues of medical justification and cost-effectiveness.
Absolute Event Rate: 0% vs 0%
Many of the 40 000 transcatheter procedures so far carried out cannot be justified on medical or cost effectiveness grounds. Hans Van Brabandt, Mattias Neyt, and Frank Hulstaert examine why practice has gone beyond the evidence
Brabandt et al. (Tue,) reported a other. Transcatheter aortic valve implantation (TAVI) has expanded beyond clinical evidence, with many of the 40,000 procedures performed lacking medical or cost-effectiveness justification.